Amkay Products IPO Opens With A Stellar 90% Premium, Lists At ₹104.5 On BSE SME platformAmkay Products IPO Opens With A Stellar 90% Premium, Lists At ₹104.5 On BSE SME platform

Amkay Products had an impressive market debut on the BSE SME, opening at Rs 104.5, a 90% increase over the initial issue price of Rs 55. This strong start indicates significant investor confidence in the company’s potential.

The public offering of Rs 12.61 crore, involving 22.92 lakh shares, was overwhelmingly subscribed 748 times due to strong investor demand. Non-institutional investors subscribed 987.34 times their quota, while retail investors subscribed 973 times their reserved portion, showing significant market enthusiasm.

Founded in 2008 in Mumbai, Amkay Products Limited has grown from a single product to a diverse portfolio of over 30 medical devices and healthcare products, including surgical disposables and home healthcare items. Their ISO 9001:2015 accredited 26,000 sq. ft. facility supports robust manufacturing and testing, reflecting their expansion through strategic acquisitions and continuous growth in the medical industry.

Amkay Products Limited aims to invest INR 50.20 lakhs in capital expenditures for new machinery and INR 800.00 lakhs in working capital to enhance capacity and operational efficiency, with the remaining funds allocated for general corporate purposes.